Key patent granted

We are happy to announce that the key patent covering our platform technology of our ophthalmic drug delivery system has been granted in the US, in Europe and in Japan. It cements that our technology is entirely unique and that we have full freedom to operate in finalizing the first fully functionable prototype that is reproducible in large numbers.